2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure P Ponikowski, AA Voors, SD Anker, H Bueno, JGF Cleland, AJS Coats, ... Kardiologia Polska (Polish Heart Journal) 74 (10), 1037-1147, 2016 | 20073* | 2016 |
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial Heart Protection Study Collaborative Group The Lancet 360 (9326), 7-22, 2002 | 8923 | 2002 |
Effect of carvedilol on survival in severe chronic heart failure M Packer, AJS Coats, MB Fowler, HA Katus, H Krum, P Mohacsi, ... New England Journal of Medicine 344 (22), 1651-1658, 2001 | 4456 | 2001 |
Ethical authorship and publishing AJS Coats International journal of cardiology 131 (2), 149-150, 2009 | 2142 | 2009 |
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) MD Flather, MC Shibata, AJS Coats, DJ Van Veldhuisen, A Parkhomenko, ... European heart journal 26 (3), 215-225, 2005 | 2054 | 2005 |
Guidelines for the diagnosis and treatment of chronic heart failure WJ Remme, K Swedberg European heart journal 22 (17), 1527-1560, 2001 | 2048 | 2001 |
Ferric carboxymaltose in patients with heart failure and iron deficiency SD Anker, J Comin Colet, G Filippatos, R Willenheimer, K Dickstein, ... New England Journal of Medicine 361 (25), 2436-2448, 2009 | 1983 | 2009 |
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 1854 | 2021 |
Wasting as independent risk factor for mortality in chronic heart failure SD Anker, P Ponikowski, S Varney, TP Chua, AL Clark, KM Webb-Peploe, ... The Lancet 349 (9058), 1050-1053, 1997 | 1583 | 1997 |
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study M Packer, MB Fowler, EB Roecker, AJS Coats, HA Katus, H Krum, ... Circulation 106 (17), 2194-2199, 2002 | 1544 | 2002 |
GLIM criteria for the diagnosis of malnutrition–a consensus report from the global clinical nutrition community T Cederholm, GL Jensen, M Correia, MC Gonzalez, R Fukushima, ... Journal of cachexia, sarcopenia and muscle 10 (1), 207-217, 2019 | 1535 | 2019 |
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial Heart Protection Study Collaborative Group The Lancet 360 (9326), 23-33, 2002 | 1495 | 2002 |
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care MR Cowie, AD Struthers, DA Wood, AJS Coats, SG Thompson, ... The Lancet 350 (9088), 1349-1353, 1997 | 1349 | 1997 |
Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. AJ Coats, S Adamopoulos, A Radaelli, A McCance, TE Meyer, L Bernardi, ... Circulation 85 (6), 2119-2131, 1992 | 1286 | 1992 |
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance JA McCrohon, JCC Moon, SK Prasad, WJ McKenna, CH Lorenz, ... Circulation 108 (1), 54-59, 2003 | 1271 | 2003 |
Incidence and aetiology of heart failure; a population-based study MR Cowie, DA Wood, AJS Coats, SG Thompson, PA Poole-Wilson, ... European heart journal 20 (6), 421-428, 1999 | 1244 | 1999 |
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they … NG Bellenger, MI Burgess, SG Ray, A Lahiri, AJS Coats, JGF Cleland, ... European heart journal 21 (16), 1387-1396, 2000 | 1142 | 2000 |
Sarcopenia with limited mobility: an international consensus je Morley, am Abbatecola Journal of the American Medical Directors Association 12 (6), 403-409, 2011 | 1040 | 2011 |
Plasma cytokine parameters and mortality in patients with chronic heart failure M Rauchhaus, W Doehner, DP Francis, C Davos, M Kemp, C Liebenthal, ... Circulation 102 (25), 3060-3067, 2000 | 1039 | 2000 |
Endotoxin and immune activation in chronic heart failure: a prospective cohort study J Niebauer, HD Volk, M Kemp, M Dominguez, RR Schumann, ... The Lancet 353 (9167), 1838-1842, 1999 | 1022 | 1999 |